Most GVHD patients should have insurance, which would be how they paid for an expensive bone marrow transplant.
Developing GVHD greatly increases the cost of post transplant care, and insurance companies should be willing to pay a lot for a cure which can greatly reduce these post transplant costs.
https://www.astctjournal.org/article/S2666-6367(23)01362-3/fulltext
Most GVHD patients should have insurance, which would be how...
-
- There are more pages in this discussion • 2,300 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.045(3.50%) |
Mkt cap ! $1.518B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.35 | $1.30 | $2.885M | 2.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 7070 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |